Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Receivables (2017 - 2019)

Historic Receivables for Cogent Biosciences (COGT) over the last 3 years, with Q4 2019 value amounting to $2.0 million.

  • Cogent Biosciences' Receivables rose 1990.41% to $2.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $2.0 million, marking a year-over-year increase of 1990.41%. This contributed to the annual value of $2.0 million for FY2019, which is 1990.41% up from last year.
  • As of Q4 2019, Cogent Biosciences' Receivables stood at $2.0 million, which was up 1990.41% from $880000.0 recorded in Q3 2019.
  • Cogent Biosciences' Receivables' 5-year high stood at $2.0 million during Q1 2019, with a 5-year trough of $830000.0 in Q4 2017.
  • Over the past 3 years, Cogent Biosciences' median Receivables value was $1.5 million (recorded in 2019), while the average stood at $1.5 million.
  • In the last 5 years, Cogent Biosciences' Receivables skyrocketed by 10096.39% in 2018 and then plummeted by 3798.45% in 2019.
  • Cogent Biosciences' Receivables (Quarter) stood at $830000.0 in 2017, then surged by 100.96% to $1.7 million in 2018, then grew by 19.9% to $2.0 million in 2019.
  • Its Receivables stands at $2.0 million for Q4 2019, versus $880000.0 for Q3 2019 and $1.5 million for Q2 2019.